Innovative Models in the Rehabilitation of the Elderly With Hip Fractures Through Technological Innovation

Assistive Robotic in the Elderly: Innovative Models in the Rehabilitation of the Elderly With Hip Fractures Through Technological Innovation

The final goals of the present study is to propose a new approach in the hip fracture rehabilitation in elderly subjects, focused on the use of robotic device and to check the results not only at the end of the treatment but also in the long term, foreseeing 3 follow-up.

Study Overview

Detailed Description

Balance and deficit in walking are some of the main characteristics of aging and are considered among the risk factors for falls. Falls are a risk factor for future falls and are associated with other adverse health outcomes such as fear of falling or fractures. In particular, hip fracture in aged patients is an important health problem. In fact, one in three patients dies within the first year after injury, while survivors have poor quality of life For this reason, the development of prevention tools and innovative strategies in the rehabilitation field should be one of the main objectives in the treatment of the diseases afflicting the elderly, such as hip fractures. Effective interventions to promote hip recovery post hip fracture are characterized by intensive and repetitive movements. One treatment approach to increase number of steps during rehabilitation sessions and to improve the balance and the endurance of the patients is the use of robotic systems.

This study is a randomized controlled trial. A total of 195 patients with hip fractures will be recruited and randomly divided into three groups, to receive a traditional rehabilitation program or a robotic rehabilitation in addition to the traditional therapy. Assessments will be performed at baseline, at the end of treatment and 6 months, 1 year and 2 years from the end of the treatment. For the study, post-hospitalization subjects will be taken into consideration, after four weeks from the hospitalization. A 20 treatment sessions will be conducted, divided into 3 training sessions per week, for 7 weeks. The control group will perform traditional therapy sessions lasting 50 minutes. The technological intervention group will carry out 30 minutes of traditional therapy and 20 minutes of treatment with a robotic system.

Study Type

Interventional

Enrollment (Estimated)

195

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ancona, Italy, 60131
        • Recruiting
        • INRCA Research Hospital
        • Principal Investigator:
          • Giovanni Riccardi
        • Contact:
      • Fermo, Italy
        • Recruiting
        • INRCA Research Hospital
        • Principal Investigator:
          • Pietro Scendoni
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Capacity to consent
  • Traumatic event within 60 days
  • Romberg test: negative
  • Functional Ambulation Category (FAC) score ≤ 2
  • Ranking scale score ≤ 3;

Exclusion Criteria:

  • Past history of syncopal episodes
  • Presence of non-pharmacologically compensated behavioral syndromes
  • Presence of pain that prevents walking or standing
  • Presence of neurological pathologies that compromise balance (Multiple sclerosis, Parkinson's disease, stroke, ataxias, poliomyelitis)
  • Spinal stenosis
  • Radiculopathy
  • Neuropathies lower limbs
  • Disabling disabilities that impair walking (eg congenital malformations of the foot)
  • Heterometry > 2 cm
  • Clinical dementia rating (CDR) score ≥ 3
  • Severe systemic diseases with life expectancy < 1 year
  • Patients unable to follow up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: control group
Ten traditional physical treatment sessions divided into 2 training sessions per week for 5 weeks
Each session will include 50 minutes of traditional physical rehabilitation therapy
Experimental: virtual reality games arm
Ten technological treatment sessions divided into 2 training sessions per week for 5 weeks.
Each session will include 30 minutes of traditional physical rehabilitation therapy followed by 20 minutes of robotic training by Tymo system (Tyromotion, Austria), a wireless platform for the balance and the postural control training that simulates floor walking and stairs climbing. Tymo system is connected to a screen and provides virtual reality games, adaptable to the functional capacity of the patient. Through the games proposed, the physiotherapist will decide to work in a dimension (antero-posterior or medio-lateral dimension) or in two dimensions (combining the antero-posterior and medio-lateral movements).
Experimental: robotic treadmill arm
Ten traditional physical treatment sessions divided into 2 training sessions per week for 5 weeks.
Each session will include 30 minutes of traditional physical rehabilitation therapy followed by 20 minutes of robotic training by Walker view (TecnoBody, Italy), a treadmill equipped with a sensorized belt with eight load cells and a 3D camera.to detect length, speed and symmetry of the pace and load, range of the trunk, hips and knees. Patients will be asked to walk at a comfortable speed, while the physiotherapist will be able to work on different parameters such as step length, load distribution, and step height. The setting will take place taking into account the clinical conditions of each patient, customizing the intervention. The Walker View will offer visual and auditory feedback to the patient, so as to correct gait in real time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
difference in falling risk among virtual reality games arm, robotic treadmill arm and control arm
Time Frame: before treatment, and 5 weeks, 6 months, 12 months and 24 months after intervention commencement
falling risk will be evaluated by the Tinetti performance oriented mobility assessment (POMA). POMA test has two subscales, Balance and Gait sections. Total score is obtained by adding the scores of the two subscales (balance + gait) . Total score < 19 high fall risk, total score 19-24 medium fall risk, total score 25-28 low fall risk
before treatment, and 5 weeks, 6 months, 12 months and 24 months after intervention commencement

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
difference in gait performance among virtual reality games arm, robotic treadmill arm and control arm
Time Frame: before treatment, and 5 weeks, 6 months, 12 months and 24 months after intervention commencement
gait performance will be evaluated by the walking speed evaluated by instrumental gait analysis
before treatment, and 5 weeks, 6 months, 12 months and 24 months after intervention commencement
difference in fear of falling among virtual reality games arm, robotic treadmill arm and control arm
Time Frame: before treatment, and 5 weeks, 6 months, 12 months and 24 months after intervention commencement
fear of falling will be evaluated by the Falls Efficacy Scale - International (FES-I). Higher scores represent greater the fear of falling (ranging from 16 to 64)
before treatment, and 5 weeks, 6 months, 12 months and 24 months after intervention commencement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giovanni Riccardi, IRCCS-INRCA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 26, 2019

Primary Completion (Estimated)

March 30, 2024

Study Completion (Estimated)

March 30, 2024

Study Registration Dates

First Submitted

September 16, 2019

First Submitted That Met QC Criteria

September 18, 2019

First Posted (Actual)

September 19, 2019

Study Record Updates

Last Update Posted (Actual)

October 23, 2023

Last Update Submitted That Met QC Criteria

October 20, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • INRCA_03_2019

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on traditional rehabilitation

Subscribe